Evidence map›Paper›PMID 23899677›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2013

Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection.

Carolyn V Gould, Jonathan R Edwards, Jessica Cohen, Wendy M Bamberg, Leigh Ann Clark, Monica M Farley, Helen Johnston, Joelle Nadle, Lisa Winston, Dale N Gerding and 3 more

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Global burden ofJournal of global health · 2019
    Pooled it
  3. Guideline
  4. Attributable Costs ofJournal of Korean medical science · 2025
    Article
  5. Three stages of laboratory stewardship in improving appropriateAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  6. Potential underreporting of treated patients using aInfection control and hospital epidemiology · 2024
    Observational
  7. Incidence ofJournal of Korean medical science · 2024
    Observational
  8. Use of electronic health record data to identify hospital-associatedmedRxiv : the preprint server for health sciences · 2024
    Article
  9. The changing epidemiology ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  10. Article
  11. Laboratory diagnosis of Clostridioides difficile infection in symptomatic patients: what can we do better?Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  12. Trends inAnnals of medicine · 2022
    Article
  13. Review
  14. Treatment and Outcomes ofJournal of clinical medicine · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Journal of clinical medicine · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Carolyn V GouldDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention.
Jonathan R Edwards
Jessica Cohen
Wendy M Bamberg
Leigh Ann Clark
Monica M Farley
Helen Johnston
Joelle Nadle
Lisa Winston
Dale N Gerding
L Clifford McDonald
Fernanda C Lessa
Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention
Centers for Disease Control and Prevention · USCenters for Disease Control and Prevention · UGLoyola University Chicago · USAtlanta Research and Education Foundation · USEmory University · USIbis Reproductive Health · USUniversity of California, San Francisco · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.

Indexed as

Clostridium InfectionsHumansIncidenceMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesSensitivity and Specificityclinical laboratory techniquesClostridium difficileincidencenucleic acid amplification techniquessurveillance

Identifiers

PMID23899677
PMCPMC9580544
OpenAlexW2118381291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.